Previous 10 | Next 10 |
2024-02-21 08:34:43 ET Losers: Pop Culture Group Co Ltd ( CPOP ) -33% . Shineco ( SISI ) -27% . Palo Alto Networks PANW -24% after Q2 earnings release . Biofrontera ( BFRI ) -23% . Amplitude AMPL -22% after Q4 earnings release . ...
2023-10-26 18:23:02 ET Avinger, Inc. (AVGR) Q3 2023 Earnings Conference Call October 26, 2023, 4:30 PM ET Company Participants Matt Kreps - Investor Relations Jeff Soinski - Chief Executive Officer Nabeel Subainati - Principal Financial Officer Conference C...
2023-10-26 16:15:10 ET Avinger press release ( NASDAQ: AVGR ): Q3 GAAP EPS of -$2.92. Revenue of $1.8M (-11.8% Y/Y). Cash and cash equivalents totaled $8.7 million as of September 30, 2023. For further details see: Avinger GAAP EPS of -$2.92, revenue of $1.8M
REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Avinger Inc. (AVGR) is expected to report $-2.85 for Q3 2023
2023-10-25 17:35:50 ET More on Avinger Avinger, Inc. (AVGR) Q2 2023 Earnings Call Transcript Avinger raises $5.3M via at-the-market facility Avinger jumps 28%, enters ATM equity offering Seeking Alpha’s Quant Rating on Avinger Historical earnin...
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its finan...
Avinger, Inc. (NASDAQ: AVGR) is one of today's top gainers. The company's shares are currently up 17.56% on the day to $6.23. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to trea...
2023-09-27 08:18:13 ET More on Avinger Avinger, Inc. (AVGR) Q2 2023 Earnings Call Transcript Avinger jumps 28%, enters ATM equity offering Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avinger Financial information for Av...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of ...
Advances New OCT-Guided Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / May 15, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatme...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...